STK25 and hepatocellular carcinoma: We next complemented the bioinformatic assessment of STK25 expression in publicly available datasets with an analysis of STK25 mRNA abundance in the liver biopsies from an independent cohort of patients with HCC (N= 48) and control subjects (N = 214) recruited at the University Hospital of Tübingen (Tübingen, Germany) using reverse transcription quantitative polymerase chain reaction (RT-qPCR).